315 related articles for article (PubMed ID: 33897381)
1. Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.
Nguyen LH; Bordey A
Front Neuroanat; 2021; 15():664695. PubMed ID: 33897381
[TBL] [Abstract][Full Text] [Related]
2. Epilepsy in the mTORopathies: opportunities for precision medicine.
Moloney PB; Cavalleri GL; Delanty N
Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
[TBL] [Abstract][Full Text] [Related]
3. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
Nguyen LH; Mahadeo T; Bordey A
J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.
Nguyen LH; Bordey A
Front Neuroanat; 2021; 15():715363. PubMed ID: 34295225
[TBL] [Abstract][Full Text] [Related]
5. The mTOR pathway genes
Nguyen LH; Xu Y; Nair M; Bordey A
Elife; 2024 Feb; 12():. PubMed ID: 38411613
[TBL] [Abstract][Full Text] [Related]
6. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.
Weckhuysen S; Marsan E; Lambrecq V; Marchal C; Morin-Brureau M; An-Gourfinkel I; Baulac M; Fohlen M; Kallay Zetchi C; Seeck M; de la Grange P; Dermaut B; Meurs A; Thomas P; Chassoux F; Leguern E; Picard F; Baulac S
Epilepsia; 2016 Jun; 57(6):994-1003. PubMed ID: 27173016
[TBL] [Abstract][Full Text] [Related]
7. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy.
Dawson RE; Nieto Guil AF; Robertson LJ; Piltz SG; Hughes JN; Thomas PQ
Neurobiol Dis; 2020 Feb; 134():104640. PubMed ID: 31639411
[TBL] [Abstract][Full Text] [Related]
8. The mTOR pathway genes
Nguyen LH; Xu Y; Nair M; Bordey A
bioRxiv; 2024 Jan; ():. PubMed ID: 37609221
[TBL] [Abstract][Full Text] [Related]
9. Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies.
Coleman M; Pinares-Garcia P; Stephenson SE; Lee WS; Kooshavar D; Mclean CA; Howell KB; Leventer RJ; Reid CA; Lockhart PJ
Neurol Genet; 2024 Apr; 10(2):e200135. PubMed ID: 38496361
[TBL] [Abstract][Full Text] [Related]
10. The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy.
Brandt C; Hillmann P; Noack A; Römermann K; Öhler LA; Rageot D; Beaufils F; Melone A; Sele AM; Wymann MP; Fabbro D; Löscher W
Neuropharmacology; 2018 Sep; 140():107-120. PubMed ID: 30081001
[TBL] [Abstract][Full Text] [Related]
11. Current Approaches and Future Directions for the Treatment of mTORopathies.
Karalis V; Bateup HS
Dev Neurosci; 2021; 43(3-4):143-158. PubMed ID: 33910214
[TBL] [Abstract][Full Text] [Related]
12. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
Citraro R; Leo A; Constanti A; Russo E; De Sarro G
Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
[TBL] [Abstract][Full Text] [Related]
13. GATOR1 complex: the common genetic actor in focal epilepsies.
Baldassari S; Licchetta L; Tinuper P; Bisulli F; Pippucci T
J Med Genet; 2016 Aug; 53(8):503-10. PubMed ID: 27208208
[TBL] [Abstract][Full Text] [Related]
14. DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.
Iffland PH; Baybis M; Barnes AE; Leventer RJ; Lockhart PJ; Crino PB
Neurobiol Dis; 2018 Jun; 114():184-193. PubMed ID: 29481864
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N-methyl-D-aspartate receptors.
Pineau L; Buhler E; Tarhini S; Bauer S; Crepel V; Watrin F; Cardoso C; Represa A; Szepetowski P; Burnashev N
Epilepsia; 2024 May; ():. PubMed ID: 38717560
[TBL] [Abstract][Full Text] [Related]
16. mTOR dysregulation and tuberous sclerosis-related epilepsy.
Curatolo P; Moavero R; van Scheppingen J; Aronica E
Expert Rev Neurother; 2018 Mar; 18(3):185-201. PubMed ID: 29338461
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Target of Rapamycin Pathway in Epileptic Disorders.
Kim JK; Lee JH
J Korean Neurosurg Soc; 2019 May; 62(3):272-287. PubMed ID: 31085953
[TBL] [Abstract][Full Text] [Related]
18. The role of somatic mutational events in the pathogenesis of epilepsy.
Iffland PH; Crino PB
Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss.
Cullen ER; Safari M; Mittelstadt I; Weston MC
Elife; 2024 Mar; 12():. PubMed ID: 38446016
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
